Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
2647 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2024-12-31 (geneonline.com)
A Look at 2024’s Patent Expirations and Generic Competition -
2024's patent expirations, the rise of generics, and their impact on pharmaceutical companies, revenue, and patient access.
Read more
2024-11-20 (biospace.com)
Biogen, UCB Reveal Details Behind Surprise Late-Stage Win in Lupus, Eyes Second Phase III
After the unexpected success of their PHOENYCS GO study for dapirolizumab pegol in lupus earlier this fall, Biogen and UCB are planning a second late-stage trial by the end of the year to support a drug application.
Read more
2024-11-19 (dagensmedicin.se)
Biogen wins prize for best patient information with togetherinsma.se
Biogen has won the Apotekarsocieteten award for best patient information 2020 for the website togetherinsma.se.
Read more
2024-10-31 (biospectator.com)
Biogen signs 1.45 billion won deal with Neomorph, “Molecular adhesive enters the war”
Reporter Jeong Ji-yoon, Biospectator
Read more
2024-10-30 (endpts.com)
Sage, Biogen won't pursue major depression approval for postpartum pill
It’s official: Sage and Biogen will not attempt to get their postpartum depression pill Zurzuvae approved in the broader population of people with major depressive disorder. Sage, which has recently ...
Read more
2024-10-09 (morningstar.com)
Biogen Gets FDA Breakthrough Designation for Kidney-Transplant Drug
By Colin Kellaher
Read more
2024-06-25 (nachrichten-heute.net)
Biogen's sustainable location in Solothurn: Awards for European production facility
Munich: Sustainability goals, productivity and profitability successfully combined at Biogen: All laboratories of the Swiss ...
Read more
2024-06-11 (devdiscourse.com)
Panel Backs Eli Lilly's Alzheimer’s Drug: Donanemab Takes a Step Forward
Advisers to the U.S. FDA voted unanimously that the benefits of Eli Lilly's experimental Alzheimer's drug donanemab outweigh its risks. The treatment aims to slow disease progression by targeting toxic beta amyloid plaques.
Read more
2024-05-28 (drugdiscoverytrends.com)
Analyzing the biotech and pharma layoffs in 2024
More than 5,600 biotech and pharma workers lost jobs since the start of 2024, with Big Pharma driving the majority.
Read more